STJ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
STJ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
St Jude Medical's Total Assets for the quarter that ended in Sep. 2016 was $12,541 Mil.
Total Assets is connected with ROA %. St Jude Medical's annualized ROA % for the quarter that ended in Sep. 2016 was 6.73%. Total Assets is also linked to Revenue through Asset Turnover. St Jude Medical's Asset Turnover for the quarter that ended in Sep. 2016 was 0.12.
The historical data trend for St Jude Medical's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
St Jude Medical Annual Data | |||||||||||||||||||||
Trend | Dec06 | Dec07 | Dec08 | Dec09 | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | |||||||||||
Total Assets | Get a 7-Day Free Trial | 9,118.00 | 9,271.00 | 10,248.00 | 10,193.00 | 12,900.00 |
St Jude Medical Quarterly Data | ||||||||||||||||||||
Dec11 | Mar12 | Jun12 | Sep12 | Dec12 | Mar13 | Jun13 | Sep13 | Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | |
Total Assets | Get a 7-Day Free Trial | 11,125.00 | 12,900.00 | 12,552.00 | 12,658.00 | 12,541.00 |
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
St Jude Medical's Total Assets for the fiscal year that ended in Dec. 2015 is calculated as
Total Assets | = | Total Equity (A: Dec. 2015 ) | + | Total Liabilities (A: Dec. 2015 ) |
= | 4042 | + | 8858 | |
= | 12,900 |
St Jude Medical's Total Assets for the quarter that ended in Sep. 2016 is calculated as
Total Assets | = | Total Equity (Q: Sep. 2016 ) | + | Total Liabilities (Q: Sep. 2016 ) |
= | 4486 | + | 8055 | |
= | 12,541 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
St Jude Medical (NYSE:STJ) Total Assets Explanation
Total Assets is connected with ROA %.
St Jude Medical's annualized ROA % for the quarter that ended in Sep. 2016 is
ROA % | = | Net Income (Q: Sep. 2016 ) | / | ( (Total Assets (Q: Jun. 2016 ) | + | Total Assets (Q: Sep. 2016 )) | / count ) |
= | 848 | / | ( (12658 | + | 12541) | / 2 ) | |
= | 848 | / | 12599.5 | ||||
= | 6.73 % |
Note: The Net Income data used here is four times the quarterly (Sep. 2016) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
St Jude Medical's Asset Turnover for the quarter that ended in Sep. 2016 is
Asset Turnover | ||||||
= | Revenue (Q: Sep. 2016 ) | / | ( (Total Assets (Q: Jun. 2016 ) | + | Total Assets (Q: Sep. 2016 )) | / count ) |
= | 1499 | / | ( (12658 | + | 12541) | / 2 ) |
= | 1499 | / | 12599.5 | |||
= | 0.12 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Thank you for viewing the detailed overview of St Jude Medical's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Jeff Fecho | officer: VP, Global Quality | ONE ST. JUDE MEDICAL DRIVE ST. PAUL MN 55117 |
Philip Ebeling | officer: VP, Chief Technology Officer | INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY MN 55416 |
Donald Zurbay | officer: VP Finance and CFO | C/O ST. JUDE MEDICAL, INC., ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117 |
Michael A Rocca | director | C/O LIGAND PHARMACEUTICALS INCORPORATED, 10275 SCIENCE CENTER DRIVE, SAN DIEGO CA 92121 |
Barbara B Hill | director | |
Wendy L Yarno | director | |
Stuart Essig | director | 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536 |
John C Heinmiller | officer: Executive Vice President | ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117 |
John W Brown | director | STRYKER CORP, 2725 FAIRFIELD ROAD, KALAMAZOO MI 49002 |
David C Dvorak | director | C/O ZIMMER INC, PO BOX 708, WARSAW IN 46580 |
Michael T Rousseau | director, officer: Director, President and CEO | ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117 |
Eric S Fain | officer: Group President | ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN MN |
Daniel J Starks | director | ONE ST JUDE MEDICAL DRIVE, ST PAUL MN 55117 |
Joel Becker | officer: President, Americas | ONE ST. JUDE MEDICAL DRIVE, ST. PAUL MN 55418 |
Rohan Hoare | officer: President - NMD | 100 CYBERONICS BLVD, HOUSTON TX 77058 |
From GuruFocus
By gurufocus 10qk • 08-11-2010
By GuruFocus Research GuruFocus Editor • 11-06-2009
By Sydnee Gatewood Sydnee Gatewood • 08-15-2016
By Victor Selva Victor Selva • 04-30-2014
By GuruFocus Research GuruFocus Editor • 10-30-2009
By Tiziano Frateschi Tiziano Frateschi • 11-14-2016
By gurufocus • 08-03-2006
By GuruFocus Research GuruFocus Editor • 02-04-2010
By GuruFocus Research GuruFocus Editor • 05-14-2010
By GuruFocus Research GuruFocus Editor • 02-11-2010
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.